When patients with post-TAVR infective endocarditis have a stroke, their risk of in-hospital mortality and all-cause mortality after one year both skyrocket. 

The USPSTF said there is not enough evidence to recommend for or against taking supplements to prevent CVD or cancer. The two exceptions are vitamin E and beta-carotene, which the group warned should not be taken for that purpose. 

The TAP-CHF trial is expected to enroll up to 100 AFib patients with a history of HFpEF. 

The full analysis will be presented May 17 at ACC.21. 

Researchers emphasized the importance of these findings, noting that hypertension can lead to significant cardiovascular complications.

The global event, now in its second year, is raising money for Doctors Without Borders. 

Researchers in Germany explored data from more than 400 TAVR patients, sharing their findings in the Journal of the American College of Cardiology. 

The full analysis is scheduled to be presented May 16 at ACC.21.

The last two weeks saw market clearances granted in Europe for AI-based software focused on remote patient monitoring, prostate oncology and real-time guidance of coronary stenting.